Pharmacogenomics of CRC treatments: putting bricks on the path to personalized medicine
Main Authors: | Fernández-Rozadilla, Ceres, Balboa, Emilia, Rasool, Mahmood, Barros, Francisco, Castells, Antoni, Castellvi-Bel, Sergi, Brea-Fernández, Alejandro, Ruiz-Ponte, Clara, Carracedo, Angel |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075479/ |
Similar Items
-
A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12
by: Fernandez-Rozadilla, Ceres, et al.
Published: (2013) -
Partnering route helps robots put bricks in their place
Published: (2010) -
Delimiting Allelic Imbalance of TYMS by Allele-Specific Analysis
by: Balboa-Beltrán, Emilia, et al.
Published: (2015) -
A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS
by: Rosmarin, Dan, et al.
Published: (2015) -
Putting Rac1 on the Path to Glucose Uptake
by: Rudich, Assaf, et al.
Published: (2013)